close
The new BIESTMILCH chewable tablets arrived

NO SORBITOL IN OUR NEW CHEWABLE TABLETS ANYMORE

The BIESTMILCH team is pleased to present the new chewable tablet to you. It no longer contains sorbitol, instead it contains maltodextrin as a matrix for the tablet. We have also improved the feeling of biting and the solubility on the tongue. It also got a little more lemon taste from us. It no longer tastes so flat and boring. We hope that these changes are entirely in your interest.

The BIESTMILCH chewable tablet as an integral part of a prevention concept is highly recommended. We should have learned the lesson from prevention with Corona, namely, that prevention is more important than treatment. Biestmilch is foodstuff and can be safely integrated into your own diet plan.

Ventilators are perfectly suited to spread particles like viruses.
Corona, though an innocent particle, may show us the way and take prevention generally more seriously.
This is a beautiful inflorescence, but could be interpreted as a virus as well. Shapes are formless, shapes are flexible, their realm is huge.

BIESTMILCH chewable tablets are very well suited to bring your allergic deregulated immune system into a more stable balance over time (with regular intake). Allergic symptoms usually become weaker under BIESTMILCH, as the inflammatory processes calm down. A new balance is created on a more robust level.

A remark at the end: Please don’t confuse the symptoms of the virus infection CORVID-19 with those of an allergy flare-up!!  >> the path to our shop

Susann

Susann

Susann is the biest prototype and head of the team. She is Austrian, has studied medicine, meaning she is a medical doctor and the Biesters' alpha wolf. Susann continuously produces new ideas, is strong in making concepts and is practically always ON FIRE. Without her BIESTMILCH wouldn't be where and what it is today, and anyway - not possible.

Stormy weather at the third winter run and a BIESTMILCH no show

BIEST BOOSTER special offer – 25% crisis deduction

Leave a Response